These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 28214281)
1. Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database. Amini A; Raben D; Crawford ED; Flaig TW; Kessler ER; Lam ET; Maroni P; Pugh TJ Urol Oncol; 2017 Jun; 35(6):438-446. PubMed ID: 28214281 [TBL] [Abstract][Full Text] [Related]
2. Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy. Liu Y; Patel SA; Jani AB; Gillespie TW; Patel PR; Godette KD; Hershatter BW; Shelton JW; McDonald MW Clin Genitourin Cancer; 2021 Jun; 19(3):255-266.e7. PubMed ID: 32972877 [TBL] [Abstract][Full Text] [Related]
3. Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis. Stokes WA; Kavanagh BD; Raben D; Pugh TJ Pract Radiat Oncol; 2017; 7(4):270-278. PubMed ID: 28673554 [TBL] [Abstract][Full Text] [Related]
4. Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer. Jackson MW; Amini A; Jones BL; Kavanagh B; Maroni P; Frank SJ; Mahmood U; Kudchadker RJ; Pugh TJ Brachytherapy; 2017; 16(4):790-796. PubMed ID: 28442277 [TBL] [Abstract][Full Text] [Related]
5. Differences in Patterns of Care and Referral Between Proton and Photon Therapy. Hasan S; Verma V; Abel S; Wegner RE; Choi JI; Press RH; Chhabra A; Simone CB Int J Part Ther; 2024 Mar; 11():100005. PubMed ID: 38757072 [TBL] [Abstract][Full Text] [Related]
6. Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice? Muralidhar V; Rose BS; Chen YW; Nezolosky MD; Nguyen PL Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):313-317. PubMed ID: 27496390 [TBL] [Abstract][Full Text] [Related]
7. Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018. Nogueira LM; Sineshaw HM; Jemal A; Pollack CE; Efstathiou JA; Yabroff KR JAMA Netw Open; 2022 Apr; 5(4):e228970. PubMed ID: 35471569 [TBL] [Abstract][Full Text] [Related]
8. Patterns of Care in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. Odei B; Frandsen JE; Boothe D; Ermoian RP; Poppe MM Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):60-63. PubMed ID: 27816365 [TBL] [Abstract][Full Text] [Related]
9. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer. Zelefsky MJ; Moughan J; Owen J; Zietman AL; Roach M; Hanks GE Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1053-61. PubMed ID: 15234039 [TBL] [Abstract][Full Text] [Related]
10. Differential Use of Radiotherapy Fractionation Regimens in Prostate Cancer. Qureshy SA; Diven MA; Ma X; Marciscano AE; Hu JC; McClure TD; Barbieri C; Nagar H JAMA Netw Open; 2023 Oct; 6(10):e2337165. PubMed ID: 37815829 [TBL] [Abstract][Full Text] [Related]
11. Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer. Yang DD; Muralidhar V; Nguyen PL; Buzurovic I; Martin NE; Mouw KW; Devlin PM; Trinh QD; Orio PF; King MT Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):904-911. PubMed ID: 29063853 [TBL] [Abstract][Full Text] [Related]
12. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis. Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175 [TBL] [Abstract][Full Text] [Related]
14. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis. Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107 [TBL] [Abstract][Full Text] [Related]
15. Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy. Yang DD; Muralidhar V; Mahal BA; Nguyen PL; Devlin PM; King MT; Orio PF Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):53-58. PubMed ID: 29254781 [TBL] [Abstract][Full Text] [Related]
16. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer. Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899 [TBL] [Abstract][Full Text] [Related]
17. National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study. Mahal BA; Chen YW; Efstathiou JA; Muralidhar V; Hoffman KE; Yu JB; Feng FY; Beard CJ; Martin NE; Orio PF; Nguyen PL Cancer; 2016 May; 122(10):1505-12. PubMed ID: 26970022 [TBL] [Abstract][Full Text] [Related]
18. Proton therapy expansion under current United States reimbursement models. Kerstiens J; Johnstone PA Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):235-40. PubMed ID: 24685152 [TBL] [Abstract][Full Text] [Related]
19. External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis. Hoffman KE; Hong TS; Zietman AL; Russell AH Cancer; 2008 Feb; 112(4):943-9. PubMed ID: 18098220 [TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]